FDA Issues Emergency Use Authorization for Zoetis Simparica TRIO to Combat New World Screwworm

The Quick Take

• The FDA issued an Emergency Use Authorization for Simparica TRIO to treat New World Screwworm infestations in dogs and puppies.
• Simparica TRIO, made by Zoetis, combines sarolaner, moxidectin, and pyrantel to treat the myiasis-causing parasite.
• The EUA signals an active New World Screwworm threat requiring emergency veterinary intervention beyond approved product labeling.
• Zoetis stands to benefit from accelerated veterinarian adoption of Simparica TRIO in affected regions under the EUA framework.

The FDA's Emergency Use Authorization for Simparica TRIO—Zoetis's branded combination of sarolaner, moxidectin, and pyrantel—to treat New World Screwworm infestations in dogs and puppies represents a significant regulatory event for the animal health sector. New World Screwworm, a parasitic fly that causes myiasis, has been subject to active USDA eradication efforts in Central America for decades, and any resurgence requiring EUA-level response indicates meaningful spread risk. The EUA pathway shortens the typical regulatory timeline significantly, granting Simparica TRIO access to a new therapeutic indication while the USDA and FDA coordinate containment efforts.

For Zoetis, the EUA represents an incremental revenue opportunity in the parasiticide segment beyond Simparica TRIO's core flea, tick, and heartworm indications. The animal health sector's competitive dynamics will be watched closely by peers Elanco Animal Health and Boehringer Ingelheim to determine whether New World Screwworm spread expands the addressable parasiticide market or creates a temporary product-specific advantage for Zoetis. Veterinary distributors and clinic operators benefit from increased Simparica TRIO prescription volume, while livestock producers in proximity to affected areas may face secondary economic impact from screwworm infestation risk in cattle.

The forward signal to watch is the CDC and USDA's geographic containment update—if New World Screwworm spread expands northward into US cattle states from Central American origin regions, the economic scale of the outbreak escalates dramatically from a pet-health issue to a livestock industry emergency. Watch Zoetis's Q3 earnings commentary for any quantification of EUA-driven Simparica TRIO volume uplift. The macro variable: USDA's sterile insect technique eradication program funding and effectiveness, which determines whether this EUA represents a temporary emergency measure or signals a structural return of screwworm as an endemic threat requiring long-term parasiticide management.

Synthesized from 1 source.